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Summary 
The cause of the initial synaptic disconnection and eventual widespread neuronal 
degeneration that underlies the onset and progressive development of dementia in 
sufferers of Alzheimer’s disease (AD) remains elusive. The pathognomonic features 
of AD, extracellular accumulations of soluble and fibrillar β-amyloid (Aβ) as well as 
intracellular neurofibrillary tangles comprised of hyperphosphorylated tau, that give 
rise to characteristic dystrophic neurites and neuropil threads, respectively, have been 
studied extensively in human AD cases and a variety of transgenic mouse models. 
Nonetheless, the degree to which these malformations affect different populations of 
neurons and their synaptic connections in the cortex remains to be defined. 
Furthermore, although white matter degeneration has previously been implicated in 
AD, not much is known about the extent of myelin loss in AD. This thesis, therefore, 
sought to address four aims analyzing the relationship between AD pathology and 
the mechanisms underlying AD. Firstly, to investigate the extent to which 
interneuron subpopulations are susceptible to Aβ plaque-mediated cytoskeletal 
alterations compared to a neurofilament-rich pyramidal neuron population. Secondly, 
to examine the relationship between Aβ plaque deposition and inhibitory and 
excitatory synaptic connections. Thirdly, to assess if the activity of glutamate 
decarboxylase, the enzyme catalysing the formation of the inhibitory 
neurotransmitter GABA, is altered in a transgenic mouse model of AD. Finally, to 
determine if AD pathology is associated with cortical demyelination and 
oligodendrocyte cell loss in human and transgenic mice. 
The major conclusions drawn from these investigations were that inhibitory 
interneuron neurites were not as susceptible to Aβ plaque-mediated dystrophy as 
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neurofilament-rich neurites. Moreover, GABAergic synaptic density was not 
significantly decreased in proximity to Aβ plaques unlike excitatory glutamatergic 
synapse density. These decreases were accompanied by potentially compensatory 
changes in presynaptic bouton size, perisomatic innervation, as well as increased 
gliotransmission of GABA in Aβ plaque-rich neuropil. Neuritic plaque deposition 
was also associated with focal demyelination and concomitant decreases in several 
integral myelin-associated proteins. Interestingly, although mature oligodendrocyte 
loss was also present, there were significant increases in the number of immature 
oligodendrocytes and precursor cells, indicative of a reactive remyelinating response. 
In summary, this thesis further clarified the pathological role of Aβ plaques in 
mediating cytoskeletal dystrophic changes and specific synaptic loss. It also 
identified the novel finding of focal demyelination associated with Aβ deposits. A 
better understanding of these early pathological alterations in the progression of AD 
is necessary for the development of effective therapeutic strategies. In particular, the 
compensatory changes in response to ongoing AD pathology could offer promising 
endogenous targets for slowing or repairing neuronal dysfunction.  
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